Full Text View
Tabular View
No Study Results Posted
Related Studies
X-Chromosome Inactivation Status and Premature Ovarian Failure
This study is ongoing, but not recruiting participants.
Study NCT00295087   Information provided by University of Pittsburgh
First Received: February 17, 2006   Last Updated: March 11, 2009   History of Changes

February 17, 2006
March 11, 2009
November 2005
November 2008   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00295087 on ClinicalTrials.gov Archive Site
 
 
 
X-Chromosome Inactivation Status and Premature Ovarian Failure
X-Chromosome Inactivation Status and Premature Ovarian Failure

Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.

Premature ovarian failure (POF) affects approximately 1% of women. For most women a cause is not found, but structural abnormalities of the X-chromosome commonly lead to POF, suggesting genes on the X-chromosome are necessary for normal ovarian function. It is known that certain gene mutations on the X-chromosome can lead to changes in the normal random pattern of X-chromosome inactivation in females.

We propose to study X-inactivation patterns in a cohort of women with idiopathic POF, and compare their pattern to a mean age-matched cohort of women with normal menstrual function.

We hypothesize that some women with POF will show skewed X-inactivation, suggesting a mutation on the X-chromosome as the etiology of their POF.

 
Observational
Cohort, Cross-Sectional
Premature Ovarian Failure
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
40
May 2009
November 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Women diagnosed with POF.
  • A chromosomal analysis must have been performed to evaluate X-chromosomal abnormalities, and the results are known to be normal.

Exclusion Criteria:

  • Patients who have a known etiology for their POF and/or an inability to obtain karyotype results for these patients or unknown X-chromosome abnormalities.
Female
20 Years to 40 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00295087
W. Allen Hogge, MD, University of Pittsburgh/Magee-Womens Hospital
0511043
University of Pittsburgh
 
Principal Investigator: W. Allen Hogge, MD University of Pittsburgh and Magee-Womens Hospital
University of Pittsburgh
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP